Data, physician awareness, and patient education can help us assess whats best for each patient, medication or bariatric surgery
By following these tips, you can make semaglutide injections more comfortable and maintain a positive outlook on your treatment journey
Most weight loss occurs during the first year of taking semaglutide
Semaglutide belongs to a group of drugs called glucagon-like peptide 1 receptor agonists (GLP-1 receptor agonists)
The study findings include: By week 120, participants who were previously on semaglutide regained two-thirds of their body weights after a year without receiving the maximum dose of Wegovy (2.4 mg weekly) Similarly, cardiometabolic improvements from week 0 to week 68 from semaglutide also declined at week 120
There are many patients that reach their desired weight loss without doing any diet or exercise